17.82
price up icon3.30%   0.57
 
loading
Precedente Chiudi:
$17.25
Aprire:
$17.6046
Volume 24 ore:
10,150
Relative Volume:
0.15
Capitalizzazione di mercato:
$929.11M
Reddito:
-
Utile/perdita netta:
$-143.59M
Rapporto P/E:
-6.3111
EPS:
-2.8236
Flusso di cassa netto:
$-119.47M
1 W Prestazione:
+1.48%
1M Prestazione:
+8.07%
6M Prestazione:
-3.88%
1 anno Prestazione:
+5.76%
Intervallo 1D:
Value
$17.24
$18.10
Intervallo di 1 settimana:
Value
$16.72
$18.10
Portata 52W:
Value
$11.51
$25.50

Pharvaris Nv Stock (PHVS) Company Profile

Name
Nome
Pharvaris Nv
Name
Telefono
-
Name
Indirizzo
-
Name
Dipendente
119
Name
Cinguettio
Name
Prossima data di guadagno
2024-08-05
Name
Ultimi documenti SEC
Name
PHVS's Discussions on Twitter

Confronta PHVS con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
PHVS
Pharvaris Nv
17.82 929.11M 0 -143.59M -119.47M -2.8236
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
457.03 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
547.74 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
329.77 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
545.11 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
244.32 28.51B 3.81B -644.79M -669.77M -6.24

Pharvaris Nv Stock (PHVS) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-06-11 Iniziato Guggenheim Buy
2025-04-29 Iniziato Cantor Fitzgerald Overweight
2023-09-25 Iniziato Wedbush Outperform
2023-08-15 Aggiornamento Morgan Stanley Equal-Weight → Overweight
2022-10-05 Iniziato Bryan Garnier Buy
2022-09-13 Ripresa JMP Securities Mkt Outperform
2022-08-23 Downgrade Morgan Stanley Overweight → Equal-Weight
2022-08-22 Downgrade BofA Securities Neutral → Underperform
2022-05-25 Iniziato JMP Securities Mkt Outperform
2021-03-02 Iniziato BofA Securities Neutral
2021-03-02 Iniziato Morgan Stanley Overweight
2021-03-02 Iniziato Oppenheimer Outperform
2021-03-02 Iniziato SVB Leerink Outperform
Mostra tutto

Pharvaris Nv Borsa (PHVS) Ultime notizie

pulisher
Jun 16, 2025

(PHVS) Trading Advice - news.stocktradersdaily.com

Jun 16, 2025
pulisher
Jun 16, 2025

Pharvaris presents new data on oral angioedema treatment at EAACI By Investing.com - Investing.com UK

Jun 16, 2025
pulisher
Jun 16, 2025

Clinical Trial Results: Revolutionary Oral HAE Drug Prevents Attacks and Improves Quality of Life in 97.8% of Patients - Stock Titan

Jun 16, 2025
pulisher
Jun 14, 2025

Analysts Set Pharvaris (NASDAQ:PHVS) Price Target at $36.20 - Defense World

Jun 14, 2025
pulisher
Jun 12, 2025

Pharvaris (NASDAQ:PHVS) Now Covered by Analysts at Guggenheim - Defense World

Jun 12, 2025
pulisher
Jun 12, 2025

Cantor Fitzgerald Weighs in on Pharvaris FY2026 Earnings - Defense World

Jun 12, 2025
pulisher
Jun 11, 2025

Pharvaris (PHVS) Gains Buy Rating with Promising Market Potentia - GuruFocus

Jun 11, 2025
pulisher
Jun 11, 2025

Bank of America Corp DE Increases Stake in Pharvaris (NASDAQ:PHVS) - Defense World

Jun 11, 2025
pulisher
Jun 11, 2025

Guggenheim Initiates Coverage on Pharvaris With Buy Rating, $32 Price Target - marketscreener.com

Jun 11, 2025
pulisher
Jun 11, 2025

Pharvaris (PHVS) Receives New Buy Rating and $32 Target from Gug - GuruFocus

Jun 11, 2025
pulisher
Jun 11, 2025

Millennium Management LLC Trims Stake in Pharvaris (NASDAQ:PHVS) - Defense World

Jun 11, 2025
pulisher
Jun 10, 2025

Pharvaris Schedules Key Shareholder Meeting: What HAE Treatment Investors Should Know - Stock Titan

Jun 10, 2025
pulisher
Jun 10, 2025

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Purchases 14,838 Shares of Pharvaris (NASDAQ:PHVS) - Defense World

Jun 10, 2025
pulisher
Jun 09, 2025

What is Leerink Partnrs’ Forecast for Pharvaris Q2 Earnings? - Defense World

Jun 09, 2025
pulisher
Jun 07, 2025

Pharvaris (NASDAQ:PHVS) Given “Outperform” Rating at Wedbush - Defense World

Jun 07, 2025
pulisher
Jun 05, 2025

Pharvaris (PHVS) Receives Continued "Outperform" Rating from Wedbush | PHVS Stock News - GuruFocus

Jun 05, 2025
pulisher
Jun 05, 2025

Pharvaris (PHVS) Receives Continued "Outperform" Rating from Wed - GuruFocus

Jun 05, 2025
pulisher
Jun 05, 2025

Citizens JMP reiterates Market Outperform rating for Pharvaris stock By Investing.com - Investing.com UK

Jun 05, 2025
pulisher
Jun 04, 2025

Transcript : Pharvaris N.V.Special Call - marketscreener.com

Jun 04, 2025
pulisher
Jun 02, 2025

Pharvaris (PHVS) Spotlights Promising Deucrictibant Data at Key Workshop | PHVS Stock News - GuruFocus

Jun 02, 2025
pulisher
Jun 02, 2025

Pharvaris reports promising results for deucrictibant in HAE By Investing.com - Investing.com UK

Jun 02, 2025
pulisher
Jun 01, 2025

Pharvaris (NASDAQ:PHVS) Shares Acquired by Deutsche Bank AG - Defense World

Jun 01, 2025
pulisher
May 27, 2025

Northern Trust Corp Purchases 76,188 Shares of Pharvaris (NASDAQ:PHVS) - Defense World

May 27, 2025
pulisher
May 24, 2025

How To Trade (PHVS) - news.stocktradersdaily.com

May 24, 2025
pulisher
May 20, 2025

Cubist Systematic Strategies LLC Purchases New Holdings in Pharvaris (NASDAQ:PHVS) - Defense World

May 20, 2025
pulisher
May 19, 2025

New Clinical Data Reveals Long-Term Success of Oral HAE Treatment Deucrictibant - Stock Titan

May 19, 2025
pulisher
May 18, 2025

Pharvaris (NASDAQ:PHVS) Shares Gap Down – Here’s What Happened - Defense World

May 18, 2025
pulisher
May 18, 2025

Brokers Offer Predictions for Pharvaris FY2025 Earnings - Defense World

May 18, 2025
pulisher
May 17, 2025

Q2 Earnings Forecast for Pharvaris Issued By Leerink Partnrs - Defense World

May 17, 2025
pulisher
May 17, 2025

Cantor Fitzgerald Cuts Pharvaris (NASDAQ:PHVS) Price Target to $25.00 - Defense World

May 17, 2025
pulisher
May 17, 2025

Research Analysts Issue Forecasts for Pharvaris Q2 Earnings - Defense World

May 17, 2025
pulisher
May 16, 2025

Pharvaris (NASDAQ:PHVS) Holdings Decreased by Barclays PLC - Defense World

May 16, 2025
pulisher
May 15, 2025

The Manufacturers Life Insurance Company Reduces Stake in Pharvaris (NASDAQ:PHVS) - Defense World

May 15, 2025
pulisher
May 15, 2025

Pharvaris (NASDAQ:PHVS) Shares Down 5.1% on Disappointing Earnings - Defense World

May 15, 2025
pulisher
May 14, 2025

Transcript : Pharvaris N.V. Presents at BofA Securities 2025 Healthcare Conference, May-14-2025 08 - marketscreener.com

May 14, 2025
pulisher
May 14, 2025

PHVS Reports Decrease in Cash Reserves by March Quarter End | PH - GuruFocus

May 14, 2025
pulisher
May 14, 2025

Pharvaris (PHVS) Target Price Revised by Cantor Fitzgerald | PHV - GuruFocus

May 14, 2025
pulisher
May 14, 2025

Pharvaris (PHVS) Target Price Increased by Wedbush Amid Clinical Progress | PHVS Stock News - GuruFocus

May 14, 2025
pulisher
May 14, 2025

Wedbush Adjusts Pharvaris Price Target to $17 From $25, Maintains Outperform Rating - marketscreener.com

May 14, 2025
pulisher
May 14, 2025

(PHVS) Long Term Investment Analysis - news.stocktradersdaily.com

May 14, 2025
pulisher
May 13, 2025

Pharvaris Reports First Quarter 2025 Financial Results and Provides Business Update - marketscreener.com

May 13, 2025
pulisher
May 13, 2025

Pharvaris Hits Major FDA Milestone for HAE Drug Pipeline While Phase 3 Trials Show Strong Progress - Stock Titan

May 13, 2025
pulisher
May 13, 2025

Pharvaris (PHVS) Expected to Announce Earnings on Wednesday - Defense World

May 13, 2025
pulisher
May 12, 2025

Pharvaris to Host a Virtual R&D Call “Deucrictibant: Beyond HAE Type 1/2” on June 4 - Stock Titan

May 12, 2025
pulisher
May 07, 2025

Pharvaris (NASDAQ:PHVS) Shares Acquired by JPMorgan Chase & Co. - Defense World

May 07, 2025
pulisher
May 03, 2025

When (PHVS) Moves Investors should Listen - news.stocktradersdaily.com

May 03, 2025
pulisher
May 02, 2025

Pharvaris NV expected to post a loss of 76 cents a shareEarnings Preview - TradingView

May 02, 2025
pulisher
May 02, 2025

Geode Capital Management LLC Has $735,000 Stock Position in Pharvaris (NASDAQ:PHVS) - Defense World

May 02, 2025
pulisher
May 02, 2025

Pharvaris (NASDAQ:PHVS) Holdings Increased by Legal & General Group Plc - Defense World

May 02, 2025
pulisher
May 02, 2025

Analysts Offer Predictions for Pharvaris FY2025 Earnings - Defense World

May 02, 2025
pulisher
May 02, 2025

Pharvaris (NASDAQ:PHVS) Research Coverage Started at Cantor Fitzgerald - Defense World

May 02, 2025

Pharvaris Nv Azioni (PHVS) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$20.44
price down icon 1.45%
$36.19
price up icon 0.86%
$22.62
price up icon 6.70%
$98.24
price up icon 0.64%
$108.26
price up icon 0.70%
biotechnology ONC
$244.32
price down icon 0.34%
Capitalizzazione:     |  Volume (24 ore):